Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Desolvation of finasteride depends on environment and technique.

Human hair has more unsaturated fats inside than on the surface, and certain lipids may help bind the outer and inner layers together.

New culture method keeps human skin stem cells more stem-like.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

Minoxidil helps protect and rebuild elastic fibers in arteries, improving artery function, especially in older females.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Wnt5a slows down hair growth by blocking a specific pathway during hair regeneration.

A woman with severe angioedema improved significantly after treatment with rituximab.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document explains various skin conditions in cats and how to diagnose and treat them.

Nanoemulsion is a promising method for delivering luteolin to promote hair growth without minoxidil's side effects.

Antiandrogen therapy helps treat genetic hair loss.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

Hair and skin can regenerate without bulge stem cells due to other compensating cells.

AcSDKP may help prevent skin and hair aging and promote their growth.

Wheat straw is valuable for its health benefits and various industrial uses.